MEI Pharma

+$0.0196 (+4.21%) Today
-$0.0008 (-0.16%) As of 11:11 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MEI Pharma and other ETFs, options, and stocks.

About MEIP

MEI Pharma, Inc. is a pharmaceutical company, which engages in the clinical development of therapies for cancer. Its drug candidates include Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome.

CEO
Daniel P. Gold
Employees
76
Headquarters
San Diego, California
Founded
2000

MEIP Key Statistics

Market cap
64.58M
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.63M
High today
$0.489
Low today
$0.4498
Open price
$0.4661
Volume
1.86M
52 Week high
$3.55
52 Week low
$0.4498

MEIP News

Simply Wall StMay 18

We're Hopeful That MEI Pharma Will Use Its Cash Wisely - Simply Wall St

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost mo

MEIP Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
— per share
Actual
Expected May 31, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure